Drug intelligence / Profile preview

Yi Shen Juan Bi

Development stage
Phase 4
Lead developer
南通市中医医院
Modality
Small Molecules, Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Yi Shen Juan Bi (YSJB) is a traditional Chinese medicine (TCM) herbal compound formulation widely used in China for the treatment of rheumatoid arthritis (RA), particularly in patients with kidney deficiency syndrome as defined by TCM. The formula consists of multiple herbal and animal-derived ingredients, including Fructus Xanthii, Herba Cistanchis, Radix angelica, Radix rehmanniae, Pheretima, Radix Glycyrrhizae, Rhizoma drynariae, Polygoni cuspidati, Caulis spatholobi, Bombyx batryticatus, Herba erodii and others[6][9]. YSJB has demonstrated anti-inflammatory effects and the ability to prevent bone destruction in preclinical models of RA. Mechanistically, it modulates immune responses by regulating T cell phenotypes—specifically balancing Th17 cells and regulatory T cells (Tregs)—and inhibits osteoclast differentiation via pathways involving JAK2/STAT3 signaling and NFATc1 expression[1][3]. Clinical studies have reported that YSJB can reduce joint inflammation and bone resorption similarly to methotrexate in animal models[1], with ongoing systematic reviews evaluating its effectiveness and safety for RA patients[7][10]. The product is manufactured as a pill or tablet form.

Brand names
Yi Shen Juan Bi
Other names
Yi Shen Juan Bi PillYSJBYJB
02

Targets

JAK2 (Janus kinase 2)STAT3 (Signal Transducer and Activator of Transcription 3)

Beyond the preview

Go deeper on Yi Shen Juan Bi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yi Shen Juan Bi.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call